News & Updates

Show Multimedia Only

Balancing hope and healing in managing gynaecological tumours in children and adolescents

02 Oct 2025 by

Gynaecological tumours such as ovarian tumours in children and adolescents present complex diagnostic, emotional, and treatment challenges for young patients, families, and healthcare providers.

Balancing hope and healing in managing gynaecological tumours in children and adolescents

02 Oct 2025

Antenatal betamethasone lowers risk of respiratory morbidity in late preterm twin neonates

01 Oct 2025

Antenatal administration of betamethasone in women with twin pregnancies at risk of late preterm delivery appears to reduce the risk of neonatal respiratory morbidity, as shown in a study.

Antenatal betamethasone lowers risk of respiratory morbidity in late preterm twin neonates

01 Oct 2025

Extended risankizumab treatment for CD may be needed in some patients

01 Oct 2025 by

For some patients with Crohn’s disease (CD) who show no response to induction treatment with risankizumab, extending the treatment course is safe and improves clinical and endoscopic outcomes, as shown in a study.

Extended risankizumab treatment for CD may be needed in some patients

01 Oct 2025

Brain fog common in patients with GI disorders

01 Oct 2025

Half of the patients with common gastrointestinal (GI) disorders report experiencing brain fog (BF), reveals a study. BF prevalence is higher in patients on probiotics and those with gastroparesis and irritable bowel syndrome (IBS).

Brain fog common in patients with GI disorders

01 Oct 2025

Dose reduction does not limit efficacy of trastuzumab deruxtecan in MBC

01 Oct 2025 by

Reducing the dose of trastuzumab deruxtecan (T-DXd) does not have any significant effect on real-world (rw) progression-free survival (PFS) or treatment-related toxicities among patients with metastatic breast cancer (MBC), as shown in a Singapore study.

Dose reduction does not limit efficacy of trastuzumab deruxtecan in MBC

01 Oct 2025

Cognition-guided neurofeedback enhances response inhibition in MUD

01 Oct 2025

Cognition-guided EEG neurofeedback improves response inhibition among men with methamphetamine use disorder (MUD), a study has shown.

Cognition-guided neurofeedback enhances response inhibition in MUD

01 Oct 2025

Long COVID symptoms may persist 3 years post-infection

01 Oct 2025 by

One in five COVID-19 survivors experiences at least one unresolved symptom 3 years after the initial infection, a systematic review and meta-analysis reports.

Long COVID symptoms may persist 3 years post-infection

01 Oct 2025

Poor psychological health highly prevalent in IBD patients

01 Oct 2025

Patients with inflammatory bowel disease (IBD) commonly experience poor psychological health, which point to the possibility that physical inflammation in the gut directly influences psychological state, according to a study.

Poor psychological health highly prevalent in IBD patients

01 Oct 2025

Clesrovimab protects infants against RSV-associated LRIs, hospitalizations

01 Oct 2025 by

A single dose of clesrovimab, a long-acting monoclonal antibody, significantly reduced the incidence of respiratory syncytial virus (RSV)-associated medically attended lower respiratory infections (LRIs) and hospitalizations in healthy infants, according to the phase IIb–III CLEVER trial.

Clesrovimab protects infants against RSV-associated LRIs, hospitalizations

01 Oct 2025

Perimenopause Demystified: Helping Patients Embrace Hormonal Shifts with Menopause Hormone Therapy (MHT)

01 Oct 2025

A leading gynaecologist, Dr Premitha Damodaran provides clues on spotting symptoms of perimenopause early and treating patients optimally according to guidelines.

Perimenopause Demystified: Helping Patients Embrace Hormonal Shifts with Menopause Hormone Therapy (MHT)

01 Oct 2025

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Balancing hope and healing in managing gynaecological tumours in children and adolescents

Balancing hope and healing in managing gynaecological tumours in children and adolescents

Antenatal betamethasone lowers risk of respiratory morbidity in late preterm twin neonates

Antenatal betamethasone lowers risk of respiratory morbidity in late preterm twin neonates

Extended risankizumab treatment for CD may be needed in some patients

Extended risankizumab treatment for CD may be needed in some patients

Brain fog common in patients with GI disorders

Brain fog common in patients with GI disorders

Dose reduction does not limit efficacy of trastuzumab deruxtecan in MBC

Dose reduction does not limit efficacy of trastuzumab deruxtecan in MBC

Cognition-guided neurofeedback enhances response inhibition in MUD

Cognition-guided neurofeedback enhances response inhibition in MUD

Long COVID symptoms may persist 3 years post-infection

Long COVID symptoms may persist 3 years post-infection

Poor psychological health highly prevalent in IBD patients

Poor psychological health highly prevalent in IBD patients

Clesrovimab protects infants against RSV-associated LRIs, hospitalizations

Clesrovimab protects infants against RSV-associated LRIs, hospitalizations

Perimenopause Demystified: Helping Patients Embrace Hormonal Shifts with Menopause Hormone Therapy (MHT)

Perimenopause Demystified: Helping Patients Embrace Hormonal Shifts with Menopause Hormone Therapy (MHT)